Financials
- Market Capitalization 1.78 B
- Employee 264
- Founded 2003
- CEO Kenneth Galbraith
- Website www.zymeworks.com
- Headquarter Delaware, United States
- FIGI BBG019XSYC89
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-24.38
売上高対価格比率
18.74
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2018 | MESO Mesoblast Limited - American Depositary Shares | 13.90 USD | -2.59% | +1.39% | -6.08% | -21.91% | 1.80 B USD | ||
| 2020 | VIR Vir Biotechnology, Inc. - Common Stock | 10.61 USD | -6.11% | -6.27% | -0.93% | +77.42% | 1.80 B USD | ||
| 2033 | TRVI Trevi Therapeutics, Inc. - Common Stock | 12.29 USD | -4.95% | -5.10% | -22.61% | +19.32% | 1.75 B USD | ||
| 2034 | XNCR Xencor, Inc. - Common Stock | 23.52 USD | -6.07% | -2.08% | -3.69% | +86.96% | 1.75 B USD |